BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19307942)

  • 1. Broad usage spectrum of G protein-coupled receptors as coreceptors by primary isolates of HIV.
    Shimizu N; Tanaka A; Oue A; Mori T; Ohtsuki T; Apichartpiyakul C; Uchiumi H; Nojima Y; Hoshino H
    AIDS; 2009 Apr; 23(7):761-9. PubMed ID: 19307942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4-Dependent and CD4-independent utilization of coreceptors by human immunodeficiency viruses type 2 and simian immunodeficiency viruses.
    Liu HY; Soda Y; Shimizu N; Haraguchi Y; Jinno A; Takeuchi Y; Hoshino H
    Virology; 2000 Dec; 278(1):276-88. PubMed ID: 11112502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.
    Edinger AL; Hoffman TL; Sharron M; Lee B; O'Dowd B; Doms RW
    Virology; 1998 Sep; 249(2):367-78. PubMed ID: 9791028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use.
    Karlsson I; Antonsson L; Shi Y; Karlsson A; Albert J; Leitner T; Olde B; Owman C; Fenyö EM
    AIDS; 2003 Dec; 17(18):2561-9. PubMed ID: 14685050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1.
    Tscherning C; Alaeus A; Fredriksson R; Björndal A; Deng H; Littman DR; Fenyö EM; Albert J
    Virology; 1998 Feb; 241(2):181-8. PubMed ID: 9499793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals.
    Ostrowski MA; Justement SJ; Catanzaro A; Hallahan CA; Ehler LA; Mizell SB; Kumar PN; Mican JA; Chun TW; Fauci AS
    J Immunol; 1998 Sep; 161(6):3195-201. PubMed ID: 9743388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression.
    de Roda Husman AM; van Rij RP; Blaak H; Broersen S; Schuitemaker H
    J Infect Dis; 1999 Oct; 180(4):1106-15. PubMed ID: 10479137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coreceptor usage by HIV-1 and HIV-2 primary isolates: the relevance of CCR8 chemokine receptor as an alternative coreceptor.
    Calado M; Matoso P; Santos-Costa Q; Espirito-Santo M; Machado J; Rosado L; Antunes F; Mansinho K; Lopes MM; Maltez F; Santos-Ferreira MO; Azevedo-Pereira JM
    Virology; 2010 Dec; 408(2):174-82. PubMed ID: 20947116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia.
    Blaak H; Boers PH; Gruters RA; Schuitemaker H; van der Ende ME; Osterhaus AD
    J Virol; 2005 Feb; 79(3):1686-700. PubMed ID: 15650194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a chemokine receptor CCR5-negative T cell line and its use in determining human immunodeficiency virus type 1 phenotype.
    Binninger-Schinzel D; Müller D; Wolf T; Krause B; Meye B; Winskowsky G; Raupp S; Norley S; Brodt R; Werner A
    J Med Virol; 2008 Feb; 80(2):192-200. PubMed ID: 18098144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A formylpeptide receptor, FPRL1, acts as an efficient coreceptor for primary isolates of human immunodeficiency virus.
    Shimizu N; Tanaka A; Mori T; Ohtsuki T; Hoque A; Jinno-Oue A; Apichartpiyakul C; Kusagawa S; Takebe Y; Hoshino H
    Retrovirology; 2008 Jun; 5():52. PubMed ID: 18577234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CXC chemokine receptor, CXCR5/BLR1, is a novel and specific coreceptor for human immunodeficiency virus type 2.
    Kanbe K; Shimizu N; Soda Y; Takagishi K; Hoshino H
    Virology; 1999 Dec; 265(2):264-73. PubMed ID: 10600598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral load.
    Karlsson U; Antonsson L; Ljungberg B; Medstrand P; Esbjörnsson J; Jansson M; Gisslen M
    AIDS; 2012 Sep; 26(14):1739-44. PubMed ID: 22695299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas.
    Deutsch AJ; Aigelsreiter A; Steinbauer E; Frühwirth M; Kerl H; Beham-Schmid C; Schaider H; Neumeister P
    J Pathol; 2008 Aug; 215(4):431-44. PubMed ID: 18561120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor density.
    Willey S; Peters PJ; Sullivan WM; Dorr P; Perros M; Clapham PR
    Antiviral Res; 2005 Nov; 68(2):96-108. PubMed ID: 16157392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The promiscuous CC chemokine receptor D6 is a functional coreceptor for primary isolates of human immunodeficiency virus type 1 (HIV-1) and HIV-2 on astrocytes.
    Neil SJ; Aasa-Chapman MM; Clapham PR; Nibbs RJ; McKnight A; Weiss RA
    J Virol; 2005 Aug; 79(15):9618-24. PubMed ID: 16014924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression.
    Xiao L; Rudolph DL; Owen SM; Spira TJ; Lal RB
    AIDS; 1998 Sep; 12(13):F137-43. PubMed ID: 9764773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a new system for determination of coreceptor usages of HIV based on the human glioma NP-2 cell line.
    Soda Y; Shimizu N; Jinno A; Liu HY; Kanbe K; Kitamura T; Hoshino H
    Biochem Biophys Res Commun; 1999 May; 258(2):313-21. PubMed ID: 10329384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.
    Lin YL; Mettling C; Portalès P; Réant B; Robert-Hebmann V; Reynes J; Clot J; Corbeau P
    AIDS; 2006 Jun; 20(10):1369-77. PubMed ID: 16791011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4-independent use of the CCR5 receptor by sequential primary SIVsm isolates.
    Laurén A; Vincic E; Hoshino H; Thorstensson R; Fenyö EM
    Retrovirology; 2007 Jul; 4():50. PubMed ID: 17645788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.